IPO: Amyris, Inc

IPO: Amyris, Inc

Amyris, Inc is unique in many ways, but a synthetic biology company with a fifteen year history makes it a rare entity in a new, formative-stage industry. In 2005, Amyris partnered with the Bill & Melinda Gates Foundation to engineer yeast to make artemisinic acid, a precursor of artemisinin, an effective anti-malarial drug. In 2008, … Read more

Categories IPO

Twist Bioscience Corporation IPO

Twist Bioscience Corporation IPO

TWIST Bioscience Corp (symbol: TWST) is a leading and rapidly growing synthetic biology company that has developed a DNA synthesis platform to industrialize the engineering of biology. Twist is an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Startups Act … Read more

Categories IPO